Cargando…
Esketamine in patient with treatment resistant depression: Outcome of the temporary authorization for use programme in France
INTRODUCTION: Esketamine nasal spray has been developed for patients with treatment resistant depression. OBJECTIVES: A cohort Temporary Authorization for Use (ATUc) allowed to collect for a 6-month period the first data in real life METHODS: On 02/08/2019 the French National Agency for Medicines an...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Cambridge University Press
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9480335/ http://dx.doi.org/10.1192/j.eurpsy.2021.1834 |